ACCOUNTS - Final Accounts preparation

Creditors: Amounts falling due within one year

Registered number: 13943586

PRINCETON BIOPARTNERS LIMITED

UNAUDITED

FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 2 APRIL 2025

PRINCETON BIOPARTNERS LIMITED

REGISTERED NUMBER: 13943586

BALANCE SHEET

AS AT 2 APRIL 2025

	2 April	31 December
	2025	2023
Note	£	£


Current assets
Cash at bank and in hand		-		6,405
		-		6,405
Creditors: amounts falling due within one year	4	(1,740)		(6,613)
Net current liabilities			(1,740)		(208)
Total assets less current liabilities			(1,740)		(208)

Net liabilities			(1,740)		(208)

Capital and reserves
Called up share capital	1	1
Profit and loss account	(1,741)	(209)
	(1,740)	(208)

Page 1

PRINCETON BIOPARTNERS LIMITED

REGISTERED NUMBER: 13943586

BALANCE SHEET (CONTINUED)

AS AT 2 APRIL 2025

The Director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The Director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

Mrs T Ryder

Director

Date: 12 September 2025

The notes on pages 3 to 5 form part of these financial statements.

Page 2

PRINCETON BIOPARTNERS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 2 APRIL 2025

1.	General information

Princeton Biopartners Limited is a private company limited by share capital, registered in England and Wales.
The company's registration number is 13943586.
The company's registered office is 1 Vincent Square, London, SW1P 2PN.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Non-Going concern basis of accounting

The directors have concluded that the going concern basis is not appropriate because the Company ceased to trade during 2025 year end and all operations have been discontinued. Consequently the financial statements have been prepared on a non-going concern basis. This has had no impact on the reported results or net assets of the Company. The financial statements do not include any provision for the potential future costs for winding up the Company as no such costs were committed as at 02 April 2025.

2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

PRINCETON BIOPARTNERS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 2 APRIL 2025

2.Accounting policies (continued)

2.4

Pensions

Defined contribution pension plan

The Company contributes into a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Employees

The average monthly number of employees, including directors, during the period was 3 (2023 - 1).

Other taxation and social security	-	4,304
Other creditors	240	240
Accruals and deferred income	1,500	2,069
	1,740	6,613

5.	Pension commitments

The Company contributes into a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in a independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £4,335 (2023 - £971).

6.	Related party transactions
	At the balance sheet date, included within creditors due within one year is an amount of £240 owed to the director of the company (2023 - £240), Mrs T Ryder.

Page 4

PRINCETON BIOPARTNERS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 2 APRIL 2025

7.	Controlling party

The ultimate controlling party by virtue of her shareholding is Mrs T Ryder.

Page 5